Loading…
Onconetix, Inc. is projected to decline to $0.6787 by 2027, a -16% move from its current price of $0.8111. ONCO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.7526 | $0.8107 | $0.8734 | -0.04% |
| Aug 6 | $0.7294 | $0.8104 | $0.9004 | -0.09% |
| Aug 7 | $0.712 | $0.81 | $0.9216 | -0.13% |
| Aug 8 | $0.6977 | $0.8097 | $0.9397 | -0.17% |
| Aug 9 | $0.6852 | $0.8093 | $0.956 | -0.22% |
| Aug 10 | $0.6741 | $0.809 | $0.9709 | -0.26% |
| Aug 11 | $0.664 | $0.8086 | $0.9847 | -0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.664 | $0.8086 | $0.9847 | -0.30% |
| Week 2 | $0.6101 | $0.8062 | $1.07 | -0.60% |
| Week 3 | $0.5714 | $0.8038 | $1.13 | -0.91% |
| Week 4 | $0.5403 | $0.8013 | $1.19 | -1.21% |
| Week 5 | $0.5142 | $0.7989 | $1.24 | -1.51% |
| Week 6 | $0.4916 | $0.7965 | $1.29 | -1.80% |
| Week 7 | $0.4715 | $0.7941 | $1.34 | -2.10% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Onconetix, Inc. (ONCO) is a biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.
It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc.
in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Onconetix, Inc. is a biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The asset trades under the symbol ONCO.
It currently has a price of $0.7896 and a market capitalization of $2.91M, with a rank of 5290 among listed assets. The current price and market position reflect a biotechnology stock with a notable early-stage profile.
A major floor 35.8% below — a decisive break under it would weaken the trend.
The nearest floor, 7.7% below — buyers have tended to step in here.
The nearest ceiling, 39.3% above — a clean break opens room to run.
A major ceiling 3869.9% above — clearing it would confirm fresh momentum.
Key ONCO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ONCO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.8012 | Buy | $0.8076 | Buy |
| MA 10 | $0.8387 | Sell | $0.8244 | Sell |
| MA 20 | $0.8739 | Sell | $0.8963 | Sell |
| MA 50 | $0.992 | Sell | $2.99 | Sell |
| MA 100 | $7.24 | Sell | $21.16 | Sell |
| MA 200 | $53.70 | Sell | $746.64 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.09 | Neutral |
| Stoch RSI (14) | 87.26 | Sell |
| CCI (20) | -37.53 | Neutral |
| Williams %R (14) | -68.92 | Info |
| MACD (12,26,9) | 0.06 | Buy |
| ROC (12) | 6.85 | Buy |
| Bollinger %B (20,2) | 0.38 | Neutral |
| Stochastic %K (14) | 31.08 | Neutral |
| TRIX (15) | -2.13 | Sell |
| Awesome (5,34) | -0.13 | Sell |
| Ultimate (7,14,28) | 43.90 | Neutral |
| Momentum (10) | 0.07 | Buy |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 0.78 | Buy |
| ADX (14) | 33.32 | Sell |
| ATR (14) | 0.08 | Info |
The 30-day technical picture is neutral with RSI14 at 30. The 50-day simple moving average is $1.29 and the 200-day simple moving average is $59.10. The listed support is $0.76 and resistance is $1.13, with a 30-day price range from $0.457 to $1.36. Annualized volatility is 200.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.749 | $0.8111 | $1.10 | 0% | Neutral | |
| $0.4946 | $0.6787 | $1.01 | -16% | Bearish | |
| $0.466 | $0.6801 | $1.08 | -16% | Bearish | |
| $0.4275 | $0.6575 | $1.09 | -19% | Bearish | |
| $0.3575 | $0.5766 | $0.9983 | -29% | Bearish | |
| $0.54 | $0.9105 | $1.63 | +12% | Neutral | |
| $0.5885 | $1.04 | $1.91 | +28% | Bullish | |
| $0.4844 | $0.8873 | $1.69 | +9% | Neutral | |
| $0.4771 | $0.9091 | $1.77 | +12% | Neutral | |
| $0.4212 | $0.8343 | $1.66 | +3% | Neutral | |
| $0.5991 | $1.33 | $2.92 | +64% | Bullish | |
| $0.7893 | $1.75 | $4.03 | +116% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.749 | $0.8111 | $1.05 | +0.00% |
| September 2026 | $0.6793 | $0.8257 | $1.05 | +1.80% |
| October 2026 | $0.6326 | $0.7797 | $1.01 | -5.57% |
| November 2026 | $0.6442 | $0.8031 | $1.06 | +3.00% |
| December 2026 | $0.6564 | $0.8269 | $1.10 | +2.96% |
Click any year to see its month-by-month ONCO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ONCO is projected to trade between $0.749 and $1.10, averaging $0.8111 — a potential gain of 0% from today's $0.8111. Price action looks broadly range-bound.
Onconetix, Inc.'s 2027 outlook centres on $0.6787, within a $0.4946 to $1.01 range. That is -16% versus the projected 2026 average. That marks a -16% change versus current levels. Expect choppier, lower action through this leg of the cycle.
By 2028, ONCO could reach as high as $1.08, with a base case around $0.6801 and support toward $0.466 — roughly -16% from $0.8111. A cyclical pullback looks likely — prices rarely move in a straight line.
Expect ONCO to range from $0.4275 to $1.09 through 2029. The $0.6575 average target implies a -19% move from current prices. That is -3% versus the projected 2028 average. Expect choppier, lower action through this leg of the cycle.
The ONCO price prediction for 2030 points to an average of $0.5766 (low $0.3575, high $0.9983) — a potential decline of -29% on today's $0.8111. A cyclical pullback looks likely — prices rarely move in a straight line.
In 2031, ONCO is projected to trade between $0.54 and $1.63, averaging $0.9105 — a potential gain of +12% from today's $0.8111. That is up +58% on the projected 2030 average. A consolidation phase looks the most probable path here.
Onconetix, Inc.'s 2032 outlook centres on $1.04, within a $0.5885 to $1.91 range. That is up +14% on the projected 2031 average. That marks a +28% change versus current levels. Momentum favours further upside here.
By 2033, ONCO could reach as high as $1.69, with a base case around $0.8873 and support toward $0.4844 — roughly +9% from $0.8111. A consolidation phase looks the most probable path here.
Expect ONCO to range from $0.4771 to $1.77 through 2034. The $0.9091 average target implies a +12% move from current prices. That is up +2% on the projected 2033 average. Price action looks broadly range-bound.
The ONCO price prediction for 2035 points to an average of $0.8343 (low $0.4212, high $1.66) — a potential gain of +3% on today's $0.8111. A consolidation phase looks the most probable path here.
In 2040, ONCO is projected to trade between $0.5991 and $2.92, averaging $1.33 — a potential gain of +64% from today's $0.8111. That is up +60% on the projected 2035 average. Momentum favours further upside here.
Onconetix, Inc.'s 2050 outlook centres on $1.75, within a $0.7893 to $4.03 range. That is up +32% on the projected 2040 average. That marks a +116% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ONCO today (≈ 1,232.893601 ONCO) could be worth
$2,162.5
+$1,162.5 (+116%) by 2050 · US Dollar
Based on the average projected ONCO price of $1.75 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ONCOwould be worth at today's price.
$1,000 invested in ONCO on Jul 31, 2025 (≈ 5.617978 ONCO) would be worth
$4.56
-$995.44 (-99.5%) today · 0.00× · US Dollar
Based on a ONCO entry price of $178 vs. today's $0.8111.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.821 | $987.94 | -1.2% |
| 1 month ago | $1.08 | $751.02 | -24.9% |
| 3 months ago | $6.35 | $127.73 | -87.2% |
| 6 months ago | $70.5 | $11.5 | -98.8% |
| 1 year ago | $178 | $4.56 | -99.5% |
| All time (4.4y) ago | $9,758,000 | $0 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ONCO forecast.
Our base-case forecast reaches $1.60 around 2050.
Implied market cap at $1.60: $5.91M
The year-by-year forecast indicates a mixed near-term path followed by longer-term upside. For 2026 the avg price is $0.7896 with a 0 ROI and neutral sentiment. Through 2027-2030 the outlook shows bearish momentum, with 2027 avg $0.6597 and max $0.9806, ROI -16.4 and sentiment BEARISH; 2030 avg $0.5611 and max $0.9725, ROI -28.9 and sentiment BEARISH.
In 2031 the avg rises to $0.9143 with ROI 15.8 and neutral sentiment, and 2032 shows further gains to avg $0.997, ROI 26.3 and bullish sentiment. The forecast continues with 2033 avg $0.8447 (ROI 7, neutral), 2034 avg $0.9085 (ROI 15.1, neutral), and 2035 avg $0.8063 (ROI 2.1, neutral). By 2040 the avg price is projected at $1.32 with a 67.8 ROI and bullish sentiment, and by 2050 the avg is $1.68 with a 113 ROI and bullish sentiment.
The 2040 max is $2.91 and the 2050 max is $3.87, reflecting upside potential but with varying levels of risk. These are estimates, not guarantees.
Tap a question to reveal the answer.
Min $0.3474, avg $0.5611, max $0.9725; roiPct -28.9; sentiment BEARISH.
Near-term forecasts (2026-2030) show neutral to bearish momentum with avg prices from $0.7896 in 2026 to $0.5611 in 2030 and ROI up to -28.9; Longer-term 2031-2050 shows upside, with 2032 avg $0.997 (26.3), 2040 avg $1.32 (67.8), 2050 avg $1.68 (113) and sentiment moving toward bullish in the later years.
Yes. The max forecast by 2050 is $3.87 with ROI 113 and bullish sentiment; the 2040 max is $2.91.
Current price $0.7896; market cap $2.91M.
RSI14 is 30 with neutral sentiment. 30-day range is $0.457 to $1.36; support is $0.76 and resistance is $1.13.
Onconetix, Inc. Community Discussion
0Share your Onconetix, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.